Nurtec Prior Authorization for Cardiology: Streamlining Complex Workflows

The Dual Burden: High-Volume Drug PAs and Cardiology Workflow Complexity

Nurtec is a high-volume prior authorization target across commercial, Medicare Advantage, and Medicaid managed care plans. For cardiology practices, this drug PA layer sits atop an already demanding portfolio of prior authorizations for advanced cardiac imaging, interventional procedures, electrophysiology procedures, and specialty cardiovascular drugs. Klivira’s platform is engineered to address both the scale of high-volume drug PAs and the intricate clinical nuances of cardiology authorizations.

Prior Authorization Hotspots and Documentation Demands in Cardiology

• **Advanced Cardiac Imaging:** Stress echo, nuclear stress imaging, cardiac MRI, cardiac CT angiography, PET cardiac viability, often routed through specialty benefit-management vendors applying ACR Appropriateness Criteria.
• **Cardiac Catheterization & Interventions:** Diagnostic cardiac cath, percutaneous coronary intervention (PCI), structural-heart procedures (TAVR, MitraClip, LAA closure), requiring documentation of symptoms, functional limitation, and prior testing results.
• **Electrophysiology Procedures:** Implantable cardioverter-defibrillators (ICDs), cardiac resynchronization therapy (CRT-D, CRT-P), pacemakers, ablation procedures, with strict criteria for ejection fraction, NYHA functional class, and optimal medical therapy duration.
• **Specialty Cardiovascular Drugs:** PCSK9 inhibitors, sacubitril/valsartan, SGLT2 inhibitors for heart failure, mavacamten, and specific anticoagulants, each with payer-specific step-therapy and clinical criteria based on ACC/AHA guidelines.

Navigating High-Volume Drug PAs Like Nurtec with Klivira

While Nurtec may not be a primary cardiovascular drug, its high prior authorization volume demands efficient processing within any practice that prescribes it. Klivira's platform streamlines the submission, tracking, and management of drug PAs by automating data retrieval from EMRs and connecting directly with payer portals and pharmacy benefit managers (PBMs). This ensures that prior authorizations for medications like Nurtec are handled with the same precision and speed as other complex PAs, minimizing administrative burden and accelerating patient access.

Common Prior Authorization Denial Reasons in Cardiology

• **Inappropriate Use Criteria:** Often for advanced imaging, where the clinical question does not meet ACR appropriateness thresholds.
• **Step Therapy Requirements:** Payer mandates for conservative imaging, non-invasive testing, or trial of less expensive medications before authorizing the requested service or drug.
• **Documentation Gaps:** Insufficient or missing documentation for ejection fraction, NYHA functional class, or optimal medical therapy duration for device or heart failure drug eligibility.
• **Site-of-Service Directives:** Payers steering procedures or imaging to specific facility types (e.g., ambulatory cath labs vs. hospital-based).
• **Medical Necessity Discrepancies:** Payer assessment of clinical criteria not aligning with submitted documentation or guidelines.

Klivira's Integrated Approach for Comprehensive Cardiology and Drug PAs

Klivira’s platform delivers a unified solution for the diverse prior authorization needs of cardiology practices. By integrating with leading EMR systems via SMART on FHIR, Klivira automates the extraction of clinical data required for both complex procedural PAs and high-volume drug PAs like Nurtec. Our system intelligently routes requests, whether to payer-direct channels, X12 278, or specialty benefit-management vendors, ensuring that the right information reaches the right destination efficiently.

Klivira's Platform Capabilities for Cardiology PA Optimization

• **Specialty Benefit-Management Vendor Routing:** Automatic identification and routing of requests to vendors such as Carelon MBM, eviCore (or successor vendors), and NIA/Magellan for advanced cardiac imaging and other services.
• **ACR Appropriateness Criteria-Aware Policy Logic:** Embedded intelligence to guide documentation for advanced imaging, aligning with payer requirements for appropriateness scoring.
• **Device Prior Authorization Workflow:** Tailored workflows to accommodate the longer lead times and specific documentation for ICD, CRT, and structural-heart device implantations.
• **Specialty Drug PA Routing:** Optimized pathways for PCSK9 inhibitors, sacubitril/valsartan, SGLT2 inhibitors, and other specialty cardiovascular drugs, incorporating payer-specific step-therapy logic and ePA standards (e.g., NCPDP SCRIPT).
• **Real-time Status Tracking:** Centralized dashboard for visibility into all PA requests, including those for Nurtec and complex cardiology procedures, reducing follow-up calls and improving staff efficiency.